About Axogen
Axogen is a company based in Alachua (United States) founded in 2002. It operates as a HealthTech. Axogen has raised $62.43 million across 11 funding rounds from investors including EW Healthcare Partners, Oberland Capital and PDL BioPharma. The company has 452 employees as of December 31, 2024. Axogen offers products and services including Avance Nerve Graft. Axogen operates in a competitive market with competitors including Humacyte, Avation, CUTISS, BioCircuit and Tissue Regenix, among others.
- Headquarter Alachua, United States
- Employees 452 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Axogen, Inc.
-
Annual Revenue
$187.34 M17.81as on Dec 31, 2024
-
Net Profit
$-9.96 M54.12as on Dec 31, 2024
-
EBITDA
$4.55 M128.6as on Dec 31, 2024
-
Total Equity Funding
$62.43 M (USD)
in 11 rounds
-
Latest Funding Round
$31 M (USD), Debt – Conventional
Oct 26, 2016
-
Investors
EW Healthcare Partners
& 9 more
-
Employee Count
452
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Axogen
Axogen is a publicly listed company on the NASDAQ with ticker symbol AXGN in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Axogen
Axogen offers a comprehensive portfolio of products and services, including Avance Nerve Graft. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Nerve graft used for peripheral nerve repair.
Unlock access to complete
Sales and Marketing
107 people
Software Development Team
26 people
Leadership Team
11 people
Product Management Team
9 people
Operations Team
8 people
Senior Team
7 people
Human Resources and Administration
6 people
Staff Team
4 people
Unlock access to complete
Funding Insights of Axogen
Axogen has successfully raised a total of $62.43M across 11 strategic funding rounds. The most recent funding activity was a Debt – Conventional round of $31 million completed in October 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 11
- Last Round Debt – Conventional — $31.0M
-
First Round
First Round
(04 Dec 2007)
- Investors Count 10
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2016 | Amount | Debt – Conventional - Axogen | Valuation |
investors |
|
| Aug, 2015 | Amount | Series D - Axogen | Valuation |
investors |
|
| Nov, 2014 | Amount | Series D - Axogen | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Axogen
Axogen has secured backing from 10 investors, including venture fund investors. Prominent investors backing the company include EW Healthcare Partners, Oberland Capital and PDL BioPharma. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Growth-stage healthcare companies are invested in by EW Healthcare Partners.
|
Founded Year | Domain | Location | |
|
Structured financing solutions are provided for the global healthcare industry by Oberland Capital.
|
Founded Year | Domain | Location | |
|
Biopharmaceutical company undergoing dissolution and asset distribution processes.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Axogen
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Axogen
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Axogen Comparisons
Competitors of Axogen
Axogen operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Humacyte, Avation, CUTISS, BioCircuit and Tissue Regenix, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Human tissue-based products are developed for vascular disease applications.
|
|
| domain | founded_year | HQ Location |
Wearable tibial nerve stimulation device treats overactive bladder symptoms.
|
|
| domain | founded_year | HQ Location |
Personalized skin tissue therapy is developed by CUTISS for surgeries.
|
|
| domain | founded_year | HQ Location |
Non-invasive electrophysiology devices are developed to monitor peripheral nerves.
|
|
| domain | founded_year | HQ Location |
Developer of regenerative medical devices by using cell technology
|
|
| domain | founded_year | HQ Location |
Medical devices for peripheral nerve injury treatment are provided.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Axogen
Frequently Asked Questions about Axogen
When was Axogen founded?
Axogen was founded in 2002 and raised its 1st funding round 5 years after it was founded.
Where is Axogen located?
Axogen is headquartered in Alachua, United States. It is registered at Alachua, Florida, United States.
Is Axogen a funded company?
Axogen is a funded company, having raised a total of $62.43M across 11 funding rounds to date. The company's 1st funding round was a Series D of $1.75M, raised on Dec 04, 2007.
How many employees does Axogen have?
As of Dec 31, 2024, the latest employee count at Axogen is 452.
What is the annual revenue of Axogen?
Annual revenue of Axogen is $187.34M as on Dec 31, 2024.
What does Axogen do?
Axogen is dedicated to the development and delivery of technologies and solutions for peripheral nerve repair. The company operates in the healthcare sector, specifically targeting medical professionals and patients with nerve injuries. Solutions provided by Axogen aim to restore feeling and functionality to damaged nerves, improving quality of life. Products like Avance Nerve Graft are utilized to support nerve regeneration and recovery after traumatic injuries.
Who are the top competitors of Axogen?
What products or services does Axogen offer?
Axogen offers Avance Nerve Graft.
Is Axogen publicly traded?
Yes, Axogen is publicly traded on NASDAQ under the ticker symbol AXGN.
Who are Axogen's investors?
Axogen has 10 investors. Key investors include EW Healthcare Partners, Oberland Capital, PDL BioPharma, JAM Capital Partners, and Cardinal Partners.
What is Axogen's ticker symbol?
The ticker symbol of Axogen is AXGN on NASDAQ.